DARLA PORTER: Open Payments
NPI 1659401784 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 26 payments from 12 companies in 2025. Trend: 2023 $924 · 2024 $570 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $121 |
| AstraZeneca Pharmaceuticals LP | 4 | $106 |
| Genentech USA, Inc. | 3 | $75 |
| JAZZ PHARMACEUTICALS INC. | 2 | $67 |
| Myriad Genetic Laboratories, Inc. | 1 | $66 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| PFIZER INC. | 2 | $43 |
| Incyte Corporation | 2 | $42 |
| ARRAY BIOPHARMA INC | 1 | $29 |
Products named: TECVAYLI, ZEPZELCA, MYRISK, CALQUENCE, Tecentriq, IMFINZI, ERLEADA, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
